Provention Bio, Inc.
PRVBDelisted Apr 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001695357
Provention Bio, Inc. was delisted on Apr 27, 2023; its insiders filed their last Form 4 on Apr 28, 2023; 183 institutions reported holding it in 13F filings for Q1 2023, worth $1.47B in total; Fairfax Financial was the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Provention Bio, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 120 | 125 | +5 |
| Shares | 23.8M | 23.4M | −396.9K (−1.7%) |
| Value | $249.3M | $196.9M | −$52.5M (−21.0%) |
New holders (24)
Institutions that held Provention Bio, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (19)
Institutions that held Provention Bio, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Morgan Jess S & Co Inc | 217,050 | $2.28M |
| Putnam Investments LLC | 211,006 | $2.21M |
| Walleye Capital LLC | 103,823 | $1.09M |
| California Public Employees Retirement System | 96,800 | $1.02M |
| Bailard, Inc. | 41,400 | $434.0K |
| Ameriprise Financial Inc | 28,330 | $298.0K |
| Qube Research & Technologies Ltd | 25,270 | $265.0K |
| Marshall Wace, LLP | 24,416 | $256.0K |
| Occudo Quantitative Strategies LP | 22,755 | $239.0K |
| Trexquant Investment LP | 21,361 | $224.0K |
| Virtu Financial LLC | 19,657 | $206.0K |
| Marshall Wace North America L.P. | 17,356 | $182.0K |
| Jump Financial, LLC | 16,900 | $177.0K |
| Liberty One Investment Management, LLC | 13,200 | $139.0K |
| Pentwater Capital Management LP | 10,000 | $105.0K |
| Bank of Montreal | 2,311 | $22.0K |
| WealthShield Partners, LLC | 1,000 | $10.0K |
| International Assets Investment Management, LLC | 546 | $7.00K |
| Whittier Trust Co | 190 | $2.00K |